Welcome to Automating Quality. Mandy Gervasio is your host, and she’s on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today's episode features Steve Gens, Managing Partner at Gens & Associates. We will discuss the World Class RIM Benchmark conducted by Gens & Associates, how it came into being, and some of its key findings over time.
Gens & Associates is a Life Science advisory and benchmarking firm founded in 2005 with a focus on the regulatory domain and adjacent areas (quality, clinical, safety). Their respected research community includes active clients and members from over 140 organizations that have participated in one of their 38 benchmark studies. They expanded their benchmark capability into quality with a landmark study in 2021.
Key Takeaways
00:45 Introducing today’s topic: The World Class RIM Benchmark by Gens & Associates
01:15 Steve Gens’ Background
02:20 How did the World Class RIM come into being?
05:03 The origin of the RIM acronym
06:00 Steve shares some of the key findings of the benchmark over time
11:21 What does the industry need to get better?
13:10 Where does clinical stand compared to regulatory in terms of standardization
15:15 Is there a correlation between the ROI on new technology and having robust processes?
16:00 What has evolved over time in between those studies?
19:00 What would Steve recommend to students interested in the topic of RIM?
21:30 Thank you to our listeners!
Contact us at solabs-podcast@solabs.com
